Condition: Breast Cancer · Breast Neoplasm · Breast Cancer Female · Sponsor: Baylor Breast Care Center
The purpose of this study is to learn whether clinical response (the amount a tumor shrinks based on imaging or tumor measurements obtained by physical exam) predicts pathologic response (the amount of tumor remaining when surgery is performed) in participants with breast cancer who are receiving chemotherapy prior to surgery.
This description comes directly from the study's public registry record.
Maria Rodriguez · (713) 798-8347 · bcc-clinicalresearch@bcm.edu
Always discuss trial participation with your own doctor first.
| Harris Health System - Smith Clinic | Houston, Texas, United States | Recruiting |
| O'Quinn Medical Tower - McNair Campus - Dan L Duncan Comprehensive Cancer Center | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05020860